Salivary duct carcinoma: Immunohistochemical profile of an aggressive salivary gland tumour

Journal of Clinical Pathology

Volumn 56, Issue 12, 2003, Pages 914-918

  Etges, A ^b   Pinto Jr , D S ^a   Kowalski, L P ^c   Soares, F A ^c   Araujo V C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 2A; CYCLIN DEPENDENT KINASE 4; PROTEIN BCL 2; PROTEIN P53; RETINOBLASTOMA PROTEIN; STREPTAVIDIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; DOUBLE MINUTE CHROMOSOME; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RODENT; SALIVARY GLAND CARCINOMA; SALIVARY GLAND DUCT; TREATMENT OUTCOME;

EID: 0346150225     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.12.914     Document Type: Article

References (45)

1. Spitz MR, Batsakis JG. Major salivary gland carcinoma. Arch Otolaryngol 1984;110:45-9.
2. Ruiz CC, Romero MP, Perez MM. Salivary duct carcinoma: a report of nine cases. J Oral Maxillofac Surg 1993;51:641-6.
3. Brandwein MS, Jagirdar J, Patil J, et al. Salivary gland carcinoma (cribriform salivary gland carcinoma of excretory ducts). A clinicopathologic and immunohistochemical study of 12 cases. Cancer 1990;65:2307-14.
4. Luna MA, Batsakis JG, Ordoñez NG, et al. Salivary gland adenocarcinomas: a clinicopathologic analysis of three distinct types. Semin Diagn Pathol 1987;4:117-35.
5. Lewis JE, McKinney BC, Weiland LH, et al. Salivary duct carcinoma. Clinicopathologic and immunohistochemical review of 26 cases. Cancer 1996;77:223-30.
6. Barnes L, Rao U, Krause J, et al. Salivary duct carcinoma. Part I. A clinocopathologic evaluation and DNA image analysis of 13 cases with review of the literature. Oral Surg Oral Med Oral Pathol 1994;78:64-73.
7. Barnes L, Rao U, Contis L, et al. Salivary duct carcinoma. Part II. Immunohistochemical evaluation of 13 cases for estrogen and progesterone receptors, cathepsin D and c-erbB-2 protein. Oral Surg Oral Med Oral Pathol 1994;78:74-80.
8. Felix A, El-Naggar AK, Press MF, et al. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen and DNA content) in salivary duct carcinoma. Hum Pathol 1996;27:561-6.
9. Kamino N. Coexpression of p53 and c-erbB-2 proteins is associated with histological type, tumor stage, and cell proliferation in malignant salivary gland tumors. Virchows Arch 1996;428:75-83.
10. Martinez-Barba E, Cortes-Guardiola JA, Minguela-Puras A, et al. Salivary duct carcinoma: clinicopathologic and immunohistochemical studies. J Craniomaxillofac Surg 1997;25:328-34.
11. Madrigal B, Garcia J, De Vicente JC. Salivary duct carcinoma: an unusual case or long-term evolution. Oral Surg Oral Med Oral Pathol 1999;88:597-602.
12. Lopes MA, Alves FA, Levy BA, et al. Intraoral salivary duct carcinoma: case report with immunohistochemical observations. Oral Surg Oral Med Oral Pathol 2001;91:689-92.
13. De Araújo VC, Loducca SVL, Sobral APV, et al. Salivary duct carcinoma -cytokeratin 14 as a marker of in-situ intraductal growth. Histopathology 2002;41:244-9.
14. Kusume T, Tsuda H, Kawabata M, et al. The p16-cyclin D1/cdk-4-pRb pathway and clinical outcome in epithelial ovarian cancer. Clin Cancer Res 1999;5:4152-7.
15. INK4a and pRb in esophageal squamous cell carcinoma in the Indian population. J Cancer Res Clin Oncol 2000;126:655-60.
16. INK4A-cyclin D1) in adenoid cystic carcinoma of salivary glands. Anticancer Res 2000;20:2169-76.
17. Hellquist HB, Karlsson MG, Nilsson C. Salivary duct carcinoma - a highly aggressive salivary gland tumour with overexpression of c-erbB-2. J Pathol 1994;172:35-44.
18. Mineta H, Miura K, Takebayashi S, et al. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 2000;36:194-8.
19. Schoelch ML, Regezi JA, Dekker NP, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol 1999;35:333-42.
20. Koontongkaew S, Chareonkitkajorn L, Chanvitan A, et al. Alterations of p53, pRb, cyclin D1 and cdk4 in human oral and pharyngeal squamous cell carcinomas. Oral Oncol 2000;36:334-9.
21. Si X, Liu Z. Expression and significance of cell cycle-related proteins cyclin D1, cdk 4, p27, E2F-1 and Ets-1 in chondrosarcoma of the jaws. Oral Oncol 2001;37:431-6.
22. Mathew R, Arora S, Khanna R, et al. Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population. J Cancer Res Clin Oncol 2001;127:251-7.
23. Nevins JR. The Rb/E2F pathway and cancer. Hum Mol Genet 2001;10:699-703.
24. Bartkova J, Thullberg M, Slezak P, et al. Aberrant expression of G1-phase cell cycle regulators in flat and exophytic adenomas of the human colon. Gastroenterology 2001;120:1680-8.
25. Chen PL, Scully P, Schew J-Y, et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989;58:1193-8.
26. Hermeking H, Rago C, Schuhmacher M, et al. Identification of cdk-4 as a target of c-Myc. Proc Natl Acad Sci USA 2000;29:2229-34.
27. He TC, Sparks AB, Rago C, et al. Identification of c-Myc as a target of the APC pathway. Science 1998;281:1509-12.
28. INK4A expression in normal human adult and infant tissues. Lab Invest 1999;79:1137-43.
29. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 1995;92:6289-93.
30. Cerilli LA, Swartzbaugh JR, Saadut R, et al. Analysis of chromosome 9p21 deletion and p16 gene mutation in salivary gland carcinomas. Hum Pathol 1999;30:1242-6.
31. Bringold F, Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp Gerontol 2000;35:317-29.
32. Adams PD. Regulation of the retinoblastorna tumor suppressor protein by cyclin/cdks. Biochim Biophys Acta 2001;1471:M123-33.
33. Lundberg AS, Weinberg RA. Control of the cell cycle and apoptosis. Eur J Cancer 1999;35:531-9.
34. Kubbutat MHG, Jones SN, Vousden K. Regulation of p53 stability by Mdm2. Nature 1997;387:299-303.
35. Yamamoto T, Ikawa S, Akiyama T, et al. Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor. Nature 1986;319:230-4.
36. Lewis JE, Olsen KD, Sebo TJ. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases. Hum Pathol 2001;32:596-604.
37. Sugano S, Mukai K, Tsuda H, et al. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryongoscope 1992;102:923-7.
38. Kim YT, Kim JW, Lee JW. c-erbB-2 oncoprotein assay in ovarian carcinoma and its clinical correlation with prognostic factors. Cancer Lett 1998;132:91-7.
39. Slamon DJ, Godolphin W, Jones LA, et al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science 1989;244:707-12.
40. Cho K-J, Lee S-S, Lee Y-S. Proliferating cell nuclear antigen and c-erbb-2 oncoprotein expression in adenoid cystic carcinomas of the salivary glands. Head Neck 1999;21:414-19.
41. Press MF, Pick MC, Hung G, et al. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 1994;54:5675-82.
42. Eccles SA. Cell biology of lymphatic metastasis. The potential role of c-erbB oncogene signalling. Rec Results Cancer Res 2000;157:41-54.
43. Tan M, Yao J, Yu D. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res 1997;57:1199-205.
44. O-charoenrat PO, Rhys-Evans PH, Archer DJ, et al. C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with metalloproteinases and vascular endothelial growth factors. Oral Oncol 2002;38:73-80.
45. erbB2 is localized on cell organelles involved in cell motility. Clin Exp Metastasis 1993;11:453-61.